| Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026 |
Globe Newswire |
05/11 |
16:05 |
| Alico, Inc. Announces Financial Results for the Second Quarter Ended March 31, 2026 |
Globe Newswire |
05/11 |
16:05 |
| VirTra Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
16:05 |
| Parsons to Present at the Bank of America 2026 Industrials, Transportation & Airlines Key Leaders Conference |
Globe Newswire |
05/11 |
16:05 |
| MARA Announces First Quarter 2026 Results |
Globe Newswire |
05/11 |
16:05 |
| Rekor Systems Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
16:05 |
| Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
05/11 |
16:05 |
| Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/11 |
16:05 |
| FutureFuel Announces First Quarter 2026 Results |
Globe Newswire |
05/11 |
16:05 |
| CVRx Reports First Quarter 2026 Financial and Operating Results |
Globe Newswire |
05/11 |
16:05 |
| Life360 Reports Record Q1 2026 Results |
Globe Newswire |
05/11 |
16:05 |
| Harrow Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
16:05 |
| Abivax Announces Results of its May 11, 2026 Annual General Meeting |
Globe Newswire |
05/11 |
16:05 |
| Highwoods Announces Availability of 2025 Corporate Resiliency Report |
Globe Newswire |
05/11 |
16:05 |
| Applied Materials Announces ASU, RPI and Stanford to Join EPIC Center |
Globe Newswire |
05/11 |
16:05 |
| Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2026 |
Globe Newswire |
05/11 |
16:05 |
| Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates |
Globe Newswire |
05/11 |
16:01 |
| Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update |
Globe Newswire |
05/11 |
16:01 |
| aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting |
Globe Newswire |
05/11 |
16:01 |
| Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026 |
Globe Newswire |
05/11 |
16:01 |
| Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights |
Globe Newswire |
05/11 |
16:01 |
| Conduent Reports Significantly Improved First Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
16:01 |
| Silvercrest Asset Management Group Inc. Reports Q1 2026 Results |
Globe Newswire |
05/11 |
16:01 |
| Erasca Reports First Quarter 2026 Business Updates and Financial Results |
Globe Newswire |
05/11 |
16:01 |
| Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
16:01 |
